bharat biotech news

Bharat Biotech’s nasal vaccine, BBV154, has already completed Phase-2 trials with Covaxin. The proposed Ph-3 trials will cover those who have been administered with any two doses of the Covid-19 vaccine. Vaccine maker Bharat Biotech has…

The reports had alleged that there were some irregularities associated with the hike in the vaccine price.In a surprising development, Hyderabad-based vaccine maker Bharat Biotech has cancelled the contract to supply its Coronavirus vaccine…

In a significant development, indigenously developed Bharat Biotech's Coronavirus vaccine Covaxin has been found to be 77.8 percent effective against symptomatic Coronavirus infections, the result of the third phase of clinical trials of…

The prices for Covid-19 vaccines internationally have varied between Rs 730 to Rs 2,700 per dose.Vaccine maker Bharat Biotech on Tuesday said it was not feasible to price its Covid-19 vaccine, Covaxin at `150 per dose. The company said a…